Stock Taper
SCREENER COMPARE ANY 2 STOCKS
PROK
PROKIDNEY CORP.
NASDAQ
$1.83
▲ UP 0.55% (0.01)

KEY STATISTICS

Market Cap$615.34 M
52w High$3.48
52w Low$1.30
Dividend Yield—
Frequency—
P/E-3.45
Volume1.13M
Shares Out.148.17M

COMPANY

LEADERSHIP

Bruce Culleton
CHIEF EXECUTIVE
Bruce Culleton

COMPENSATION 2026

Salary$687,738
Stock Awards$0
Incentive Plan Pay$478,080
All Other Comp.$15,463
Total$2,956,447

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 30, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
231

PRICE TARGET

Target High$6.00
Target Low$3.00
Target Median$5.00
Target Consensus$4.67

UPCOMING EARNINGS

DateNov 9, 2026
DayMonday
Rev. Est.$124.60K
NOV
9
MON

PRICE

$1.83 ▲ UP 0.55% (+$0.01)
$1.80$1.84$1.889:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1.83

About ProKidney Corp.

https://www.prokidney.com ↗

ProKidney Corp., founded in 2015 in Winston-Salem, NC, is a clinical-stage biotech developing cellular therapies, including Renal Autologous Cell Therapy for diabetic kidney disease and congenital kidney anomalies.

INDUSTRY

Biotechnology

A PRODUCT PROKIDNEY CORP. IS KNOWN FOR

rilparencel (REACT®)
rilparencel (REACT®)

Rilparencel, a proprietary autologous cellular therapy by ProKidney, is in Phase 3 trials for CKD and type 2 diabetes patients at high risk of kidney failure, with FDA RMAT designation.

COMPETITORS

COMPETITOR
CRSP COMPARE
MAZE COMPARE
MESO COMPARE
TVTX COMPARE
VERA COMPARE

Revenue by Products

IconPRODUCTQ1-2025Q2-2025
Reportable Segment$230K $221K ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
37
LISTED HERE
10
RANKED BY POSITION SIZE
IWM
0.00% · 1.7M
VXF
0.00% · 1.3M
SCHA
0.00% · 500.4K
BBC
0.66% · 191.3K
SURI
0.33% · 156.7K
XRSG.L
0.00% · 69.2K
RSSL
0.00% · 35.9K
URTY
0.00% · 3.1K
FSEG
0.06% · 2.2K
RTYS.L
0.00% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
26.47%
HOLDERS
84
TOP 12 OF 84 · RANKED BY POSITION SIZE
Suvretta Capital Management, LLC
12.3M sh · $22.09M
Morgan Stanley
9.0M sh · $16.03M
Blackrock Inc.
3.7M sh · $8.99M
Millennium Management LLC
2.3M sh · $4.07M
Bleichroeder LP
2.0M sh · $3.58M
Artia Global Partners LP
1.8M sh · $4.12M
Vanguard Group Inc
1.6M sh · $3.69M
Hennion & Walsh Asset Management, Inc.
1.6M sh · $2.88M
Blackrock, Inc.
1.4M sh · $3.15M
Renaissance Technologies LLC
1.3M sh · $2.24M
Geode Capital Management, LLC
1.2M sh · $2.2M
Marshall Wace, Llp
1.0M sh · $1.81M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity4
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR
Pereira Brian JG
Sale · 222.9K shares
2026-08-19
★
DIRECTOR
Pereira Brian JG
Sale · 27.8K shares
2026-08-18
★
DIRECTOR
Pereira Brian JG
Sale · 27.1K shares
2026-08-20
★
DIRECTOR
Pereira Brian JG
Sale · 229.3K shares
2026-08-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY

SECTORS PEERS

PEERPRICE
TNGX$23.34COMPARE
NBTX$41.23COMPARE
SEPN$38.91COMPARE
BCAX$23.43COMPARE
TYRA$24.94COMPARE
KURA$12.66COMPARE
SVRA$5.26COMPARE
PRME$3.61COMPARE